1230 related articles for article (PubMed ID: 30362531)
21. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
Rai SN; Singh C; Singh A; Singh MP; Singh BK
Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of natural products against Alzheimer's disease via autophagic removal of Aβ.
Hu M; Ying X; Zheng M; Wang C; Li Q; Gu L; Zhang X
Brain Res Bull; 2024 Jan; 206():110835. PubMed ID: 38043648
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease.
Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J
J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841
[TBL] [Abstract][Full Text] [Related]
24. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
Bhatia V; Sharma S
J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
[TBL] [Abstract][Full Text] [Related]
25. PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy.
Fan S; Zhang B; Luan P; Gu B; Wan Q; Huang X; Liao W; Liu J
Biomed Res Int; 2015; 2015():161020. PubMed ID: 26583091
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease-related misfolded proteins and dysfunctional organelles on autophagy menu.
Correia SC; Resende R; Moreira PI; Pereira CM
DNA Cell Biol; 2015 Apr; 34(4):261-73. PubMed ID: 25664381
[TBL] [Abstract][Full Text] [Related]
27. Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer's Disease (Mouse Model) through Autophagy Induced by Activating Axl.
Qi LF; Liu S; Liu YC; Li P; Xu X
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074054
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang J; Zhang X; Yang G
Curr Neuropharmacol; 2020; 18(8):720-739. PubMed ID: 31934838
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A
Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483
[TBL] [Abstract][Full Text] [Related]
30. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways.
Song G; Li Y; Lin L; Cao Y
Mol Med Rep; 2015 Nov; 12(5):7615-22. PubMed ID: 26459718
[TBL] [Abstract][Full Text] [Related]
31. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
[TBL] [Abstract][Full Text] [Related]
32. Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer's Disease.
Rahman MA; Rahman MS; Rahman MDH; Rasheduzzaman M; Mamun-Or-Rashid A; Uddin MJ; Rahman MR; Hwang H; Pang MG; Rhim H
Biomedicines; 2020 Dec; 9(1):. PubMed ID: 33374126
[TBL] [Abstract][Full Text] [Related]
33. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
Song M; Zhao X; Song F
Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
[TBL] [Abstract][Full Text] [Related]
34. Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease.
Xiong X; Li S; Han TL; Zhou F; Zhang X; Tian M; Tang L; Li Y
Exp Cell Res; 2020 Nov; 396(1):112266. PubMed ID: 32905804
[TBL] [Abstract][Full Text] [Related]
35. mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.
Di Domenico F; Tramutola A; Foppoli C; Head E; Perluigi M; Butterfield DA
Free Radic Biol Med; 2018 Jan; 114():94-101. PubMed ID: 28807816
[TBL] [Abstract][Full Text] [Related]
36. Neurons die with heightened but functional macro- and chaperone mediated autophagy upon increased amyloid-ß induced toxicity with region-specific protection in prolonged intermittent fasting.
Ntsapi CM; Loos B
Exp Cell Res; 2021 Nov; 408(2):112840. PubMed ID: 34624324
[TBL] [Abstract][Full Text] [Related]
37. Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.
Friedman LG; Qureshi YH; Yu WH
Neurotherapeutics; 2015 Jan; 12(1):94-108. PubMed ID: 25421002
[TBL] [Abstract][Full Text] [Related]
38. Are mitophagy enhancers therapeutic targets for Alzheimer's disease?
Pradeepkiran JA; Hindle A; Kshirsagar S; Reddy PH
Biomed Pharmacother; 2022 May; 149():112918. PubMed ID: 35585708
[TBL] [Abstract][Full Text] [Related]
39. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
40. A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers.
Norambuena A; Wallrabe H; Cao R; Wang DB; Silva A; Svindrych Z; Periasamy A; Hu S; Tanzi RE; Kim DY; Bloom GS
EMBO J; 2018 Nov; 37(22):. PubMed ID: 30348864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
